Research projects per team member

Oncology

Oncological Breast Cancer Care in Selected European Countries - Organisation of healthcare infrastructures and medical service provision

Duration: Mid-April 2024 – Mid-November 2024
Language: Englisch (with German summary)
Publication: HTA Project Report No. 162: https://eprints.aihta.at/1545/

More...

High tech medicine

Robot-assisted surgery: A systematic review of effectiveness and safety in thoracic and visceral surgery

and Michaela Riegelnegg 
Duration: April 2023 – August 2023
Language: English (with German summary)

Publication: HTA Project Report No. 108: https://eprints.aihta.at/1461

More...

Psychological & psychiatric interventions

Home treatment in child and adolescent psychiatry: An analysis of effectiveness and integrated care

Duration: April 2020 – November 2020
Language: German

Publication: HTA Project report No. 129: http://eprints.aihta.at/1275/

More...

Oncology

Health Services Research (HSR) in oncology in a selected indication: Cancer therapies for lung patients

Support in data evaluation and processing: DexHelpp
Duration: October 2018 – December 2019

More...

Oncology

Health Services Research (HSR) in oncology: Analysis of Austrian data

Supported by DexHelpp (data-requirements and -acquisition), Martin Robausch
Duration: January 2018 – December 2019

Publication:

Grössmann N, Robausch M, Willenbacher W, Wolf S, Simon J, Wild C. “Magnitude of clinical benefit” of solid tumour drugs and their real-world application in the Austrian health care setting. Journal of Cancer Policy. 2020;25:100235.

More...

Oncology

Clinical benefit of oncology drugs – Contrasting the evidence of clinically relevant endpoints three years after EMA approval

Duration: December 2017 – March 2020

Publications:

Grössmann N, Robausch M, Rothschedl E, Wild C, Simon J (2019): Publicly accessible evidence of health-related quality of life benefits associated with cancer drugs approved by the European Medicines Agency between 2009 and 2015. European Journal of Cancer. 2020;129:23-31.

Grössmann N, Robausch M, Rosian K, Wild C, Simon J (2019): Monitoring evidence on overall survival benefits of anti-cancer drugs approved by the European Medicines Agency between 2009 and 2015. European Journal of Cancer 2019; 110:1-7.

More...